Please login to the form below
Managing disease
This page shows the latest Managing disease news and features for those working in and with pharma, biotech and healthcare.
Keytruda now available for untreated metastatic lung cancer patients via Cancer Drugs Fund
It has been recommended for this patient group, only if Keytruda is stopped at 2 years of uninterrupted treatment or earlier if the disease progresses. ... particularly hard to treat forms of this disease," said Louise Houson, UK managing director, MSD.
Latest news
-
Great Expectations
Consider the case of John and Maria. They both have Parkinson’s disease. ... Given the choice between a definite state of living with Parkinson’s disease and managing symptoms through usual standard-of-care drug therapy or the ‘gamble’ of an
-
Teva’s migraine injection approved in Europe
as greater flexibility in managing this unpredictable disease.”. ... Austedo for tardive dyskinesia and chorea associated with Huntington’s disease to achieve rapid take up, with both treatments now launched.
-
NICE says no to AZ and Vifor’s rival hyperkalaemia drugs
Most common in patients with poor kidney function, heart failure or liver disease, hyperkalemia can be fatal, and patients have had few options for treatment until now. ... The companies argue that this exposes patients to cardiovascular disease risk,
-
Roche wins CHMP backing for Hemlibra
disease burden of managing the disease. ... The CHMP’s recommendation is based on the results of two phase III clinical studies for people with this particular disease indication.
-
Sanofi looks to mobile data to power behavioural analysis
The three-year partnership aims to increase Sanofi’s understanding of disease burden and develop solutions from the data that will improve therapeutic outcomes. ... We can then use those insights to support patients and healthcare professionals in
More from news
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest Intelligence
-
Keeping up the fight against HIV and using the lessons to tackle other threats
over 50 and prone to other medical conditions such as heart disease and cancer. ... We have a lot of people at Gilead who have worked across Europe in HIV nursing and med- icine and know patients managing the disease so we can prioritise the projects
-
The patient’s world is ‘messy’
The patient world is multidimensional and what may seem irrelevant, clinically, may be crucial to managing and treating a disease optimally. ... The emotional and social impact of the disease is left out in order to try and speak the HCP’s
-
The EarthWorks: New ways to improve patient care
Keeping people well and preventing illness. Technology is only interesting socially when it is boring technologically; we have to have scale to begin to prevent disease on a population level. ... Managing disease and improving patient outcomes. We can
-
The logistics of orphan drugs
Managing a rare disease global access programme, the goal is to minimise risk and get the drug to the patient on time. ... When managing logistics for a global access programme, the goal must be to minimise risk and get the drug to the patient on time.
More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Cidara Therapeutics makes senior appointments
He also joins from Merck, where he has served as senior scientific director and team leader, managing programmes in areas including infectious disease, metabolic syndrome and thrombosis disease.
-
New medical communications head for S&H
In her new role at S&H Pearson will be responsible for managing its medical communications team and driving its growth in the sector. ... Prior to joining the industry Pearson was in academic research, obtaining a DPhil from the University of Oxford
-
GCI Health backs growth with new talent
Goldberg joins from Ruder Finn, where she was a senior vice president, managing global clients across multiple disease areas.
-
Kane & Finkel announces new European director
In addition, as director of communications for the UK's Health Education Authority, he also developed public health campaigns for AIDS, smoking cessation, childhood immunisation and heart disease. ... John Kane, principal and managing director of Kane
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Three strategies for managing loss of exclusivity successfully
Patients had years of experience and comfort managing their disease on their current regimen and were resistant to change.
-
A new vision for tackling key illnesses
Detecting patients at risk of CVD and preventing the disease from occurring will be key to helping the NHS achieve its ambition. ... As with other disease areas, there will be a big emphasis on engaging patients in managing their health and also on
-
Behavioural insights to navigate complex healthcare markets
The European Union alone spends 700bn (£624 bn) annually on chronic disease management. ... They pose a multi-dimensional challenge, from maintaining adherence to poly-medication and managing diseases across disease states, to delivering adequate care
-
Making good practice common practice in rare disease
These perceptions are important determinants of behaviours for managing disease’ such as adherence and coping strategies, and as a result significantly affect treatment outcomes. ... However, fatigue scores can’t be explained purely by disease
-
The changing face of primary care in the UK
And we can’t ignore the economics of primary care. The ever increasing costs of managing disease are not entirely the result of increasing medicine costs, but rather our increased knowledge ... Too often sales calls focus on an assumption of episodic
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- 20 for 2020 – Five pharma companies to watch
- Using Artificial Intelligence to Transform Pharma
- Session 4: Systems Innovation Insight and Thinking
- Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Keytruda doubles five-year survival rate in NSCLC
- EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
